Importance of bronchoscopic lung volume reduction coil therapy in potential candidates for lung transplantation

Bioscience Trends
Aşkın Gülşen

Abstract

Bronchoscopic lung volume reduction (BLVR) coil treatment is a alternative and promising treatment modality for selected severe emphysema patients. The main indication of this treatment modality is a forced expiration volume in one second (FEV1) of 15-45% and a residual volume (RV) > 175%. The aim of this study was to investigate the efficacy of BLVR coil therapy in patients with end-stage emphysema who were potential candidates for lung transplantation and had FEV1 values less than 25%. Twenty-one patients who underwent bilateral BLVR coil therapy between September 2013 and May 2015 were retrospectively reviewed. We compared the changes in clinical and laboratory parameters at the baseline and 12 months after the treatment. Twelve months after the bilateral BLVR coil treatment, we observed an average increase in FEV1 (110 mL and 4.6%), a decrease in residual volume (660 mL and 33%), and an increase in 6-minute walk tests (67 m). The most common complications were chronic obstructive pulmonary disease exacerbation (47.6%) and pneumonia (23.8%). All patients tolerated the general anesthesia and procedure very well. BLVR coil therapy is safe and effective in patients with end-stage emphysema, who are potential candidates for lung...Continue Reading

References

Mar 27, 2003·The Journal of Thoracic and Cardiovascular Surgery·Anna Maria CicconeJoel D Cooper
Nov 19, 2003·The European Respiratory Journal. Supplement·C Roussos, A Koutsoukou
Dec 2, 2006·COPD·Paul W Jones
Aug 6, 2008·Journal of Applied Physiology·Denis E O'Donnell, Katherine A Webb
Aug 10, 2010·The European Respiratory Journal·M A PuhanUNKNOWN National Emphysema Treatment Trial (NETT) Research Group
Jul 2, 2011·American Journal of Respiratory and Critical Care Medicine·Gerard J CrinerFernando J Martinez
Mar 24, 2012·The European Respiratory Journal·Jorine E HartmanDirk-Jan Slebos
Jun 2, 2012·The European Respiratory Journal·Vincent NinaneXavier Gonzalez
Jan 17, 2014·The Lancet. Respiratory Medicine·Pallav L ShahUNKNOWN RESET trial Study Group
Jun 7, 2014·Respiration; International Review of Thoracic Diseases·Karin KloosterDirk-Jan Slebos
Nov 25, 2014·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jorine E HartmanDirk-Jan Slebos
Sep 15, 2015·The Clinical Respiratory Journal·Askin GulsenHatice Yilmaz
May 18, 2016·JAMA : the Journal of the American Medical Association·Frank C SciurbaUNKNOWN RENEW Study Research Group
Nov 14, 2016·Respiration; International Review of Thoracic Diseases·Daniela GompelmannKonstantina Kontogianni
Feb 9, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Konstantina KontogianniRalf Eberhardt
Aug 18, 2017·Respiration; International Review of Thoracic Diseases·Felix J F HerthPallav L Shah
Dec 23, 2017·The European Respiratory Journal·Gaëtan DesléeUNKNOWN REVOLENS Study Group
Feb 27, 2018·Therapeutic Advances in Respiratory Disease·Marcel SimonHans Klose
Apr 2, 2018·Respiratory Medicine·Pauline V van HirtumMartijn D de Kruif

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.

Related Papers

Respirology : Official Journal of the Asian Pacific Society of Respirology
Jorine E HartmanDirk-Jan Slebos
European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
Federico VenutaGiorgio F Coloni
© 2022 Meta ULC. All rights reserved